NO176105C - Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater

Info

Publication number
NO176105C
NO176105C NO892542A NO892542A NO176105C NO 176105 C NO176105 C NO 176105C NO 892542 A NO892542 A NO 892542A NO 892542 A NO892542 A NO 892542A NO 176105 C NO176105 C NO 176105C
Authority
NO
Norway
Prior art keywords
therapeutically active
active peptide
peptide derivatives
analogous process
preparing therapeutically
Prior art date
Application number
NO892542A
Other languages
English (en)
Other versions
NO892542L (no
NO176105B (no
NO892542D0 (no
Inventor
Stephen Henderson Buck
John Leonard Krstenansky
Chester Fred Hassmann Iii
James Ray Mccarthy
Scott Lee Harbeson
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO892542D0 publication Critical patent/NO892542D0/no
Publication of NO892542L publication Critical patent/NO892542L/no
Publication of NO176105B publication Critical patent/NO176105B/no
Publication of NO176105C publication Critical patent/NO176105C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0212—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -N-C-N-C(=0)-, e.g. retro-inverso peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO892542A 1988-06-20 1989-06-19 Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater NO176105C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20892688A 1988-06-20 1988-06-20

Publications (4)

Publication Number Publication Date
NO892542D0 NO892542D0 (no) 1989-06-19
NO892542L NO892542L (no) 1989-12-21
NO176105B NO176105B (no) 1994-10-24
NO176105C true NO176105C (no) 1995-02-01

Family

ID=22776618

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892542A NO176105C (no) 1988-06-20 1989-06-19 Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater

Country Status (19)

Country Link
EP (1) EP0347802B1 (no)
JP (1) JP2711720B2 (no)
KR (1) KR0136605B1 (no)
CN (1) CN1030703C (no)
AR (1) AR246085A1 (no)
AT (1) ATE107312T1 (no)
AU (1) AU619857B2 (no)
CA (1) CA1340824C (no)
DE (1) DE68916113T2 (no)
DK (1) DK174964B1 (no)
ES (1) ES2057024T3 (no)
FI (1) FI94351C (no)
HU (1) HU204850B (no)
IE (1) IE61362B1 (no)
IL (1) IL90637A (no)
NO (1) NO176105C (no)
NZ (1) NZ229552A (no)
PT (1) PT90902B (no)
ZA (1) ZA894533B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877277A (en) 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
AU638264B2 (en) * 1989-08-10 1993-06-24 Aventis Inc. Cyclic neurokinin a antagonists
IE77033B1 (en) * 1989-08-16 1997-11-19 Univ Tulane Substance P antagonists
FR2666335B1 (fr) 1990-09-05 1992-12-11 Sanofi Sa Arylalkylamines, procede pour leur preparation et compositions pharmaceutiques les contenant.
ATE186550T1 (de) * 1991-04-22 1999-11-15 Mallinckrodt Medical Inc Verbindungen und pharmazeutische zusammensetzungen zum nachweis und zur lokalisierung von geweben mit neurokinin-1- rezeptoren
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5625060A (en) * 1991-05-03 1997-04-29 Elf Sanofi Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions on which they are present
DK0585397T3 (da) * 1991-05-23 1997-08-25 Merrell Pharma Inc Bombesinanaloger
GB9727123D0 (en) * 1997-12-22 1998-02-25 Int Centre Genetic Eng & Bio Synthesis of diamines
JP2000021345A (ja) 1998-07-06 2000-01-21 Hitachi Ltd 走査型電子顕微鏡

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1302926C (en) * 1986-03-04 1992-06-09 Hideo Sugawara Antibiotic f-0769, process for its production, and its use as a growthaccelerating and feed efficiency increasing agent and as an antitumour agent
IT1233696B (it) * 1989-05-29 1992-04-14 Menarini Farma Ind Peptidi di sintesi antagonisti della neurochinina a. loro sali e relativi procedimenti di fabbricazione
AU638264B2 (en) * 1989-08-10 1993-06-24 Aventis Inc. Cyclic neurokinin a antagonists

Also Published As

Publication number Publication date
JP2711720B2 (ja) 1998-02-10
KR910000791A (ko) 1991-01-30
FI94351C (fi) 1995-08-25
IE61362B1 (en) 1994-11-02
CA1340824C (en) 1999-11-16
PT90902B (pt) 1994-12-30
NZ229552A (en) 1992-06-25
DK301889A (da) 1989-12-21
ZA894533B (en) 1990-03-28
NO892542L (no) 1989-12-21
FI893002A (fi) 1989-12-21
DE68916113T2 (de) 1994-09-22
FI893002A0 (fi) 1989-06-19
KR0136605B1 (ko) 1998-04-25
ATE107312T1 (de) 1994-07-15
AR246085A1 (es) 1994-03-30
EP0347802A3 (en) 1991-07-17
DE68916113D1 (de) 1994-07-21
DK174964B1 (da) 2004-04-05
ES2057024T3 (es) 1994-10-16
FI94351B (fi) 1995-05-15
DK301889D0 (da) 1989-06-19
EP0347802A2 (en) 1989-12-27
AU3652389A (en) 1989-12-21
NO176105B (no) 1994-10-24
AU619857B2 (en) 1992-02-06
CN1030703C (zh) 1996-01-17
IL90637A0 (en) 1990-01-18
NO892542D0 (no) 1989-06-19
HUT50196A (en) 1989-12-28
PT90902A (pt) 1989-12-29
IL90637A (en) 1993-07-08
EP0347802B1 (en) 1994-06-15
JPH0245497A (ja) 1990-02-15
HU204850B (en) 1992-02-28
IE891987L (en) 1989-12-20
CN1039597A (zh) 1990-02-14

Similar Documents

Publication Publication Date Title
NO176759C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater
NO175371C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminosyrederivater
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
FI94254B (fi) Menetelmä terapeuttisesti aktiivisten peptidijohdannaisten valmistamiseksi
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO174547C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive didehydro-vitamin-D3-derivater
NO174467C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
NO178068C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive tiazolidindionderivater
NO175429C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive 16-dehydro-vitamin-D3-derivater
NO174959C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
NO176142C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminoalkoksyfenylderivater
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
NO178967C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazin-derivater
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO174391C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO176100C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater
NO176477C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-alkoksymetylsubstituerte kromanderivater
NO176105C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater
NO174200C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser
NO174422C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
NO176242C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 5-substituerte ornithinderivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2000